Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1

2(50.0%)

N/A

1(25.0%)

Phase 4

1(25.0%)

4Total

Phase 1(2)

N/A(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT05072821Phase 4Completed

Botulinum Toxin Type a Injection to Prevent Keloid Recurrence

Role: collaborator

NCT06457308Not ApplicableCompleted

Compare the Agility Exercise and Resistance Exercise on Physical Function and Stability in Osteoporotic Women

Role: lead

NCT05238181Unknown

Pyloric or Pseudopyloric Metaplasia of the Corpus Mucosa in Autoimmune Gastritis

Role: collaborator

NCT05191511Completed

Assessment of Safety Distance of Far-Infrared Therapeutic Device to Human Skin

Role: collaborator

NCT04436536Phase 1Unknown

Gait Speeds and Demands in Chronic Stroke Patients: A Multi-dimensional Investigation

Role: collaborator

NCT04434443Phase 1Completed

Effects of Trunk Exercise on Trunk Control and Balance in Persons With Stroke

Role: collaborator

All 6 trials loaded